Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.6, 2021 (Journal Indexed in SCI)
Article / Abstract
Title of Journal :
JOURNAL OF CLINICAL ONCOLOGY